These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1536733)

  • 1. Protein C and anti-thrombin III levels in nephrotic syndrome and amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Pediatr Nephrol; 1992 Jan; 6(1):122. PubMed ID: 1536733
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic molecular markers in nephrotic syndrome.
    Chen TY; Huang CC; Tsao CJ
    Am J Hematol; 1993 Dec; 44(4):276-9. PubMed ID: 8238000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic profile in nephrotic syndrome.
    Anand NK; Chand G; Talib VH; Chellani H; Pande J
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III, protein S, and coagulation in the nephrotic syndrome.
    Schnaper HW
    Pediatr Nephrol; 2001 Jan; 16(1):98. PubMed ID: 11198616
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
    Bashkov GV
    Biull Eksp Biol Med; 1990 Aug; 110(8):133-6. PubMed ID: 2291954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A modified method of determining antithrombin III activity by diffusion in thrombin agarose].
    Bashkov GV; Kalishevskaia TM
    Lab Delo; 1987; (8):580-4. PubMed ID: 2444745
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
    Previato G; Loschiavo C; Tessitore N; Chiaramonte S; Oldrizzi L; Lupo A; Valvo E; Maschio G; Saporiti E
    Minerva Nefrol; 1981; 28(3):421-30. PubMed ID: 7036020
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombin III deficiency and thromboembolism.
    Thaler E; Lechner K
    Clin Haematol; 1981 Jun; 10(2):369-90. PubMed ID: 7032781
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of 3 methods of study of antithrombin III].
    Nakabanda A; Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1984; (5):276-9. PubMed ID: 6204109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephrotic syndrome, renal vein thrombosis and antithrombin III levels].
    Moreno Heredia E; Gómez Carrasco J; Torres A; Aljama P; Pérez Calderón R; Canis M; Andrés P
    Rev Clin Esp; 1981 Dec; 163(6):411-4. PubMed ID: 7342205
    [No Abstract]   [Full Text] [Related]  

  • 18. [Features of thrombophilia in nephrotic syndrome in children].
    Serebrianyĭ VL; Ignatova MS; Degtiareva EM; Svetlov SI
    Pediatriia; 1989; (1):49-53. PubMed ID: 2710603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on antithrombin III in nephrotics].
    Chen WY; Chen SY; Shen MC; Yen TS; Hsieh BS; Tsai TJ; Hsu HC
    Taiwan Yi Xue Hui Za Zhi; 1985 Apr; 84(4):448-56. PubMed ID: 3860616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.